Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor
Mt. Overgaard et al., Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor, J BIOL CHEM, 275(40), 2000, pp. 31128-31133
Pregnancy-associated plasma protein-A (PAPP-A), originally known from human
pregnancy serum, has recently been demonstrated to be a metzincin superfam
ily metalloproteinase involved in normal and pathological insulin-like grow
th factor (IGF) physiology. PAPP-A specifically cleaves IGF-binding protein
(LGFBP)-4, one of six antagonists of IGF action, which results in release
of IGF bound to IGFBP-4. IGFBP-4 is the only known PAPP-A substrate. Its cl
eavage by PAPP-A uniquely depends on the presence of IGF. We here report ma
mmalian expression and purification of recombinant 1547-residue PAPP-A (rPA
PP-A). The recombinant protein is secreted as a homodimer of about 400 kDa
composed of two 200-kDa disulfide-bound subunits. Antigenically and functio
nally, rPAPP-A behaves like the native protein. In human pregnancy, PAPP-A
is known to circulate as a 500-kDa disulfide-bound 2:2 complex with the pro
form of eosinophil major basic protein (proMBP), PAPP-A/proMBP. A compariso
n between rPAPP-A and pregnancy serum PAPP-A/proMBP complex surprisingly re
veals a difference greater than 100-fold in proteolytic activity, showing t
hat proMBP functions as a proteinase inhibitor in vivo. We find that polycl
onal antibodies against PAPP-A abrogate all detectable IGFBP-4 proteolytic
activity in pregnancy serum, pointing at PAPP-A as the dominating, if not t
he only, IGFBP-4 proteinase present in the circulation. We further show tha
t pregnancy serum and plasma contain traces (<1%) of uncomplexed PAPP-A wit
h a much higher specific activity than the PAPP-A/proMBP complex. The measu
rable activity of the PAPP-A/proMBP complex probably results from the prese
nce of a minor subpopulation of partly inhibited PAPP-A that exists in a 2:
1 complex with proMBP. Inhibition of PAPP-A by proMBP represents a novel in
hibitory mechanism with the enzyme irreversibly bound to its inhibitor by d
isulfide bonds.